Literature DB >> 18386033

An epidemic of fatal 3-methylfentanyl poisoning in Estonia.

Ilkka Ojanperä1, Merja Gergov, Milana Liiv, Aime Riikoja, Erkki Vuori.   

Abstract

An exceptional epidemic of poisonings due to the highly potent opioid designer drug 3-methylfentanyl (TMF) was revealed among Estonian drug users in 2005-2006 by post-mortem forensic toxicology. Quantitative analysis of cis-TMF, trans-TMF, and fentanyl was performed by liquid chromatography-tandem mass spectrometry. Comprehensive toxicological analysis was performed using a multi-technique approach. The number of TMF-related fatal accidental poisonings identified was 46 and 71 for 2005 and 2006, respectively. The proportion of male victims was 91.5% and the mean age of all victims was 26 years at death. TMF was used predominantly by intravenous injection. There was no significant difference in the blood concentrations of cis-TMF and trans-TMF between pure TMF poisonings and mixed TMF poisonings. The mean combined concentration of TMF stereoisomers among pure TMF cases (1.9 microg/l) was more than ten times lower than the mean fentanyl concentration in fentanyl-related fatalities. Concomitant use of other drugs involved alcohol, amphetamines, benzodiazepines, and cannabis, but very rarely other opioids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18386033     DOI: 10.1007/s00414-008-0230-x

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  30 in total

1.  Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers of N-(3-methyl-1-(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide and N-(3-methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl)-N-phenylpropanamide.

Authors:  W F Van Bever; C J Niemegeers; P A Janssen
Journal:  J Med Chem       Date:  1974-10       Impact factor: 7.446

2.  Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.

Authors:  Hannu Alho; David Sinclair; Erkki Vuori; Antti Holopainen
Journal:  Drug Alcohol Depend       Date:  2006-10-19       Impact factor: 4.492

3.  Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases.

Authors:  G L Henderson
Journal:  J Forensic Sci       Date:  1991-03       Impact factor: 1.832

4.  Determination of fentanyl in human plasma and fentanyl and norfentanyl in human urine using LC-MS/MS.

Authors:  N-H Huynh; N Tyrefors; L Ekman; M Johansson
Journal:  J Pharm Biomed Anal       Date:  2005-04-29       Impact factor: 3.935

5.  Comparison of nonradioactive microtiter plate enzyme immunoassays for the sensitive detection of fentanyl.

Authors:  H Käferstein; G Sticht
Journal:  Forensic Sci Int       Date:  2000-09-11       Impact factor: 2.395

6.  Deaths after intravenous misuse of transdermal fentanyl.

Authors:  Peer K Lilleng; Lars Ivar Mehlum; Liliana Bachs; Inge Morild
Journal:  J Forensic Sci       Date:  2004-11       Impact factor: 1.832

7.  The drunkest drinking driver in Sweden: blood alcohol concentration 0.545% w/v.

Authors:  A W Jones
Journal:  J Stud Alcohol       Date:  1999-05

8.  An outbreak of designer drug--related deaths in Pennsylvania.

Authors:  J Hibbs; J Perper; C L Winek
Journal:  JAMA       Date:  1991-02-27       Impact factor: 56.272

9.  Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Interim rule with request for comments.

Authors: 
Journal:  Fed Regist       Date:  2007-04-23

10.  Fatal intravenous fentanyl abuse: four cases involving extraction of fentanyl from transdermal patches.

Authors:  Amy M Tharp; Ruth E Winecker; David C Winston
Journal:  Am J Forensic Med Pathol       Date:  2004-06       Impact factor: 0.921

View more
  8 in total

Review 1.  [Bonzai, lead and bath salt-poisoning with new and old drugs : Synthetic amphetamines, cathinones, cannabinoids and opioids-an overview].

Authors:  J Strube; A Schaper
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-02-05       Impact factor: 0.840

2.  Postmortem Toxicology Findings of Acetyl Fentanyl, Fentanyl, and Morphine in Heroin Fatalities in Tampa, Florida.

Authors:  Julia Pearson; Justin Poklis; Alphonse Poklis; Carl Wolf; Mary Mainland; Laura Hair; Kelly Devers; Leszek Chrostowski; Elise Arbefeville; Michele Merves
Journal:  Acad Forensic Pathol       Date:  2015-12

Review 3.  Blood concentrations of new synthetic opioids.

Authors:  Piotr Adamowicz; Karolina Nowak
Journal:  Int J Legal Med       Date:  2021-10-22       Impact factor: 2.686

Review 4.  The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review.

Authors:  Anneli Uusküla; Ave Talu; Sigrid Vorobjov; Maris Salekešin; Jürgen Rannap; Liis Lemsalu; Don Des Jarlais
Journal:  Int J Drug Policy       Date:  2020-05-13

5.  Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia.

Authors:  Anneli Uusküla; Mait Raag; Sigrid Vorobjov; Kristi Rüütel; Alexandra Lyubimova; Olga S Levina; Robert Heimer
Journal:  BMC Public Health       Date:  2015-12-18       Impact factor: 3.295

Review 6.  An Expanding World of Novel Psychoactive Substances: Opioids.

Authors:  Jolanta B Zawilska
Journal:  Front Psychiatry       Date:  2017-06-30       Impact factor: 4.157

Review 7.  Novel Synthetic Opioids: The Pathologist's Point of View.

Authors:  Paolo Frisoni; Erica Bacchio; Sabrine Bilel; Anna Talarico; Rosa Maria Gaudio; Mario Barbieri; Margherita Neri; Matteo Marti
Journal:  Brain Sci       Date:  2018-09-02

8.  The Experience of the Treatment Demand Indicator in Europe: A Common Monitoring Tool Across 30 Countries.

Authors:  Linda Montanari; Alessandro Pirona; Bruno Guarita; Dagmar Hedrich; Jane Mounteney; Julian Vicente
Journal:  J Stud Alcohol Drugs Suppl       Date:  2019-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.